Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vyant Bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vyant Bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hansen Paul R. | Director | 159,778 | Feb 27, 2023 | 0 |
| Fletcher R John | Director | 23,895 | Jan 19, 2023 | 0 |
| Horobin Joanna | Director | 23,123 | Jan 19, 2023 | 0 |
| Harris Geoffrey E. | Director | 19,761 | Jan 19, 2023 | 0 |
| Boehm Marcus | Director | 56,484 | Apr 19, 2022 | 0 |
| McLeod Howard | Director | 43,927 | Apr 1, 2022 | 0 |
| Yeh Yung-Ping | Director | 56,240 | Apr 1, 2022 | 0 |
| Roberts John A | Chief Executive Officer | 39,807 | Mar 17, 2022 | 0 |
| LaFrence Andrew D.C. | Chief Financial Officer | 34,292 | Mar 17, 2022 | 0 |
| Fremeau Robert Thomas Jr. | Chief Scientific Officer | 1,000 | Mar 17, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 (view filing) | Nov 18 | 4 days | Harris Geoffrey E.Director | SSaleCommon Stock, $0.0001 par value | −765 | $1.33 | −$1.02K | −5.2%14.0K after | 2 lots |
| Dec 29, 2021 (view filing) | Nov 23 | 36 days | LaFrence Andrew D.C.Chief Financial Officer | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.00 | +$10.0K | +17.1%34.3K after | Amended |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $1.69 | +$8.45K | +4.0%128.8K after | |
| Nov 24, 2021 (view filing) | Nov 24 | Same day | Roberts John AChief Executive Officer | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.02 | +$10.1K | +14.4%39.8K after | |
| Nov 23, 2021 (view filing) | Nov 22 | 1 day | Yeh Yung-PingChief Innovation Officer | PPurchaseCommon Stock, $0.0001 par value | +500 | $2.05 | +$1.02K | +4.1%12.8K after | |
| Nov 17, 2021 (view filing) | Oct 28 | 20 daysLate | Fremeau Robert Thomas Jr.Chief Scientific Officer | PPurchaseCommon Stock, $0.0001 par value | +1.00K | $2.19 | +$2.19K | New position1.00K after | |
| Oct 28, 2021 (view filing) | Oct 27 | 1 day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.10 | +$10.5K | +4.2%123.8K after | |
| Sep 30, 2021 (view filing) | Sep 29 | 1 day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.44 | +$12.2K | +4.4%118.8K after | |
| Aug 27, 2021 (view filing) | Aug 25 | 2 days | Yeh Yung-PingChief Innovation Officer | PPurchaseCommon Stock, $0.0001 par value | +1.00K | $2.64 | +$2.64K | +8.9%12.3K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.58 | +$12.9K | +4.6%113.8K after | |
| Aug 25, 2021 (view filing) | Aug 23 | 2 days | Roberts John AChief Executive Officer | PPurchaseCommon Stock, $0.0001 par value | +10.4K | $2.41 | +$25.1K | +42.6%34.8K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Hansen Paul R.Director | PPurchaseCommon Stock, $0.0001 par value | +20.0K | $2.35 | +$47.0K | +3.3%618.0K after | |
| Jul 28, 2021 (view filing) | Jul 28 | Same day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $2.92 | +$14.6K | +4.8%108.8K after | |
| Jul 1, 2021 (view filing) | May 28-Jun 30 | 34 days | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +10.0K | $3.72 | +$37.2K | +10.7%103.8K after | Amended2 lots |
| Jul 1, 2021 (view filing) | Jun 30 | 1 day | Boehm MarcusDirector | PPurchaseCommon Stock, $0.0001 par value | +5.00K | $3.76 | +$18.8K | +5.1%103.9K after |